(Newsletter) COVID-19 TESTING UPDATE – We Are Not Quite There Yet

By now, you have all been bombarded with offers for COVID-19 testing from medical suppliers. 

What’s going on? 

The Food and Drug Administration (FDA) has a process for approving new laboratory tests. During the pandemic, an Emergency Use Authorization (EUA) pathway was created to fast track approval for COVID-19 tests. On March 16, the FDA allowed commercial manufacturers to begin distributing tests under certain circumstances prior to granting an EUA1. They specifically allowed serological tests to identify antibodies to SARS-CoV-2 (COVID-19) to be distributed with some required disclaimers.

CLICK HERE to download the full newsletter.

About the Author:

Dr. Ann Jarris is a Maritime and Remote Medicine Specialist based out of Seattle, WA. She has practiced as a physician for over 15 years in urban and remote settings. Her experience is in occupational, emergency, wilderness and virtual medicine. Dr. Jarris leads innovation and research efforts at Discovery Health MD as Co-Founder and CEO.

Related Articles